As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Call for papers: Targeting cancer evolution in the clinic
The call for papers for our upcoming special issue on ‘Targeting cancer evolution in the clinic’, guest edited by Razelle Kurzrock and Alberto Bardelli is now open.
Special issue: Impact of genomics on precision public health
Our special issue on ‘The impact of genomics on precision public health’, guest edited by Muin Khoury and Kathryn Holt has now launched.
Genetic variation in the Middle East
Ahmad Abou Tayoun and Heidi Rehm highlight the lack of genomic diversity in large-scale sequencing efforts and barriers to data sharing in the Middle East.
Transcriptome-wide profiles of circRNA-RBP interactions
Jakob Skou Pedersen and colleagues generate a catalog of circRNA-RBP interactions in ENCODE cell lines and find that these could play a regulatory role in bladder cancer.
Reviews, Research Highlights and Commentaries
Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:
Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)
Articles
-
-
Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients
-
Clinical laboratory test-wide association scan of polygenic scores identifies biomarkers of complex disease
-
Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care
-
Family history assessment significantly enhances delivery of precision medicine in the genomics era
-
A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications
-
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
-
Gut microbiome-host interactions in health and disease
-
Constructing narratives of heroism and villainy: case study of Myriad's BRACAnalysis® compared to Genentech's Herceptin®
-
Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials
Focus: the Gut Microbiome
Read the latest papers on gut microbiota and disease across BMC flagship journals.
Dietary fruit and vegetable intake, gut microbiota, and type 2 diabetes: results from two large human cohort studies
Zengliang Jiang et al.
Published in BMC Medicine 03 December 2020
Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
Federico Baldini et al.
Published in BMC Biology 09 June 2020
Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma
Hechen Huang et al.
Published in Genome Medicine 23 November 2020
Lifestyle and the presence of helminths is associated with gut microbiome composition in Cameroonians
Meagan A. Rubel et al.
Published in Genome Biology 25 May 2020
Aims and scope
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
Article collections
Special issue
Translating the microbiome in health and disease
Guest editor: Ramnik Xavier
Special issue
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler
Collection
A decade of Genome Medicine
Special issue
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda
From the blog
-
Global solidarity: World AIDS Day 2020
01 December 2020
-
-
World Diabetes Day 2020: nursing education and care
12 November 2020
- Editorial Board
- Editorial Team
- Sign up for article alerts and news from this journal
- Contact us
-
Announcements
C19 Rapid Review initiative
Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here.
Submissions from medRxiv
Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.
Portable peer review
To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.
COVID-19 submissions
In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.
Follow
2019 Journal Metrics
-
Citation Impact
10.675 - 2-year Impact Factor
10.637 - 5-year Impact Factor
1.833 - Source Normalized Impact per Paper (SNIP)
5.084 - SCImago Journal Rank (SJR)
